我们如何衡量喘发作治疗的试验结果? 一个系统的审查
Imran Howell1,2, Aleksandra Howell1, Sanjay Ramakrishnan1,2,3
1Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
ERJ open research
|February 27, 2024
概括
喘发作临床试验通常测量短期的肺功能,而不是以患者为中心的结果. 需要更多的研究来确定对患者和医疗保健提供者有价值的核心结果集.
科学领域:
- 临床医学 临床医学
- 呼吸系统医学 呼吸系统医学
- 基于证据的医学基于证据的医学.
背景情况:
- 喘发作是一个重要的健康负担和成本驱动器.
- 精准医学方法需要就合适的试验结果措施达成共识.
- 在喘发作试验中目前的结果测量缺乏标准化.
研究的目的:
- 系统地审查用于治疗喘发作的随机对照试验 (RCT) 中使用的结果指标.
- 评估测量结果对患者和医疗保健提供者的适用性.
主要方法:
- 对RCT进行系统审查,比较成人喘发作的治疗方法.
- 在 MEDLINE,Embase 和 Cochrane 图书馆 (1972-2022) 进行了搜索.
- 记录了208项合格试验的结果指标和研究特征.
主要成果:
- 大多数试验 (73%) 专注于短期的肺功能变化.
- 只有27%的研究中,患者报告和医疗保健利用结果是主要的.
- 在35%的受试试验中,结果定义不清楚.
结论:
- 喘发作的RCT主要使用短期生理测量.
- 当前的结果措施可能不反映患者的优先事项或长期影响.
- 进一步调查患者对核心结果集的偏好是必不可少的.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Antiasthma Drugs: β2-Adrenoceptor Agonists
264
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
264
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Hazard Ratio
122
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
122


